This activity was developed for pulmonologists, infectious disease specialists, and other healthcare professionals who care for patients with lung diseases.
Nontuberculosis mycobacterial lung disease (NTM-LD) is a frequently fatal lung disease that is now more common than tuberculosis in the United States. Treatment is generally very challenging due to lack of medications approved for first-line therapy, adverse events, drug-drug interactions, need for long-term dual and triple combination therapy, among other issues. This is a 2-part activity. Throughout the activity, the faculty share their experiences and provide pearls and pitfalls in overcoming the challenges in managing patients with NTM-LD.
Upon completion of this activity, participants should be better able to: